"Per recommendations of EASL...http://www.easl.eu/medias/cpg/HEPC-2015/Full-report.pdf
Cirrhotic and/or treatment-experienced patients can be treated with an IFN-free combination of daily sofosbuvir (400 mg) and daily daclatasvir (60 m..."
![]() | ||||
Remove
Are you sure you want to delete your ?
You will no longer be able to add new data to this tracker. | ||||